Every one of those 1 sits in a single category, health-it. Of the tracked stories, 1 of 1 also mention FDA, the most common co-covered peer. Rare Lab appears in 1 tracked Healthcare story from March 22, 2026. The tracked stories average 3 original sources each.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Rare Lab
Every one of those 1 sits in a single category, health-it. Of the tracked stories, 1 of 1 also mention FDA, the most common co-covered peer. Rare Lab appears in 1 tracked Healthcare story from March 22, 2026. The tracked stories average 3 original sources each.
Stories tracked
1
Sources per story
3
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 13 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Rare Lab. Shared-story counts are live from our verified record — not editorial picks.
Rare Lab is pioneering a high-throughput, AI-driven approach to identify therapeutic candidates for neglected rare diseases. By integrating generative AI with automated laboratory testing, the firm aims to drastically reduce the time and cost of drug development for the world's rarest conditions.